Company News in the Life Science Industry

KANAZAWA, Japan, June 17, 2018 /PRNewswire/ --

BOSTON and STOCKHOLM, June 17, 2018 /PRNewswire/ -- Aprea Therapeutics presented results at the 2018 EHA Annual Meeting from its Phase Ib/II clinical study in MDS. The ongoing study is evaluating the safety and efficacy of APR-246 in combination with azacitidine for the treatment of TP53... Read more ››

SOUTH PLAINFIELD, N.J., June 16, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the presentation of updated interim clinical data from Part 1 of the FIREFISH study investigating risdiplam (RG7916) in babies with Type 1 Spinal Muscular Atrophy (SMA), at the... Read more ››

BENGALURU, India, June 16, 2018 /PRNewswire/ --

TOKOYO, MUNICH, and BASKING RIDGE, N.J., June 16, 2018 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that positive results from the pivotal QuANTUM-R phase 3 study of single agent quizartinib were presented today as a late-breaking oral presentation in... Read more ››

DENVER, June 16, 2018 /PRNewswire-iReach/ -- RxRevu, the industry leader in Prescription Decision Support, is proud to announce that Dr. Toby M. Cosgrove has joined their Board of Directors.

VISULAS(®) green, the next generation of photocoagulation laser from ZEISS allows doctors to fully concentrate on the patient's treatment procedure without interruption.

STOCKHOLM, June 16, 2018 /PRNewswire/ --

STOCKHOLM, June 16, 2018 /PRNewswire/ --

MILAN, June 16, 2018 /PRNewswire/ --

STOCKHOLM, June 16, 2018 /PRNewswire/ --

EAST HANOVER, N.J., June 16, 2018 /PRNewswire/ -- Novartis today announced 14-month results from the pivotal JULIET clinical trial showing ongoing durable responses are achievable with Kymriah(®) (tisagenlecleucel) when administered to adult patients with relapsed or refractory (r/r) diffuse... Read more ››

SLOUGH, England, June 15, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. District Court for the District of New Jersey has granted Indivior a temporary restraining order (TRO) that compels Dr. Reddy's (DRL) to immediately cease its launch... Read more ››

CHAPEL HILL, N.C., June 15, 2018 /PRNewswire/ -- Medical Affairs has long been a key function within the pharmaceutical industry because of its role in providing medical information to external stakeholder groups.

DUBLIN, June 15, 2018 /PRNewswire/ --

DUBLIN, June 15, 2018 /PRNewswire/ --